| PUBCHEM ID |
76000144
|
| UNII |
6A8BO41Z90
|
| Preferred Term |
BISBUTYTIAMINE
|
| CAS |
18481-23-7
|
| INCHIKEY |
YMEBNAABDXLAJE-KKTFQPMKSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CCCC(OCC/C(/SS/C(/CCOC(CCC)=O)=C(\C)/N(Cc1c(N)nc(C)nc1)C=O)=C(/C)\N(Cc1c(N)nc(C)nc1)C=O)=O
|
| Total Surface Area |
552,26
|
| Relative PSA |
0,34161
|
| TPSA |
247,42
|
| cLogS |
-6,038
|
| MW |
702,899
|
| cLogP |
5,0124
|
| H-Acceptors |
14
|
| H-Donors |
2
|
| Ro5 violations |
3
|
| Druglikeness |
0,46373
|
| DrugScore |
0,164659524761083
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
low
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,6236
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,2115
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,6975
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,3525
|
| Carcinogenicity (Three-class) |
Non-required
|
